NEU NEWMARKET CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1282637 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY2.0%
TTM EPS YoY4.1%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR4.6%
Margins
Gross margin31.7%
Operating margin20.2%
Net margin16.5%
FCF margin13.8%
EBITDA margin24.8%
Returns
ROE25.3%
ROA13.3%
ROIC (approx.)17.3%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets47.1%
Debt / equity0.43x
Current ratio2.46x
Interest coverage15.79x
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio-1.2%
Payout ratio24.4%
Capex / revenue4.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $716.50M | $747.09M | $669.72M | $635.40M | $690.31M | $698.51M | $700.95M | $654.65M |
| Cost of revenue | $494.14M | $504.67M | $448.84M | $444.62M | $480.67M | $477.56M | $464.92M | $446.96M |
| Gross profit | $222.36M | $242.43M | $220.88M | $190.78M | $209.64M | $220.95M | $236.02M | $207.69M |
| R&D expense | $30.50M | $30.39M | $31.64M | $31.52M | $35.02M | $32.37M | $33.18M | $32.84M |
| SG&A expense | $48.92M | $48.38M | $46.01M | $49.23M | $43.94M | $45.43M | $42.98M | $42.08M |
| Operating income | $142.94M | $163.66M | $143.23M | $110.03M | $130.68M | $143.15M | $159.87M | $132.76M |
| Interest expense | $7.98M | $8.82M | $8.77M | $9.88M | $8.37M | $10.73M | $10.70M | $11.64M |
| Pretax income | $151.15M | $170.34M | $151.65M | $113.15M | $135.61M | $147.69M | $164.11M | $134.25M |
| Income tax | $27.04M | $36.59M | $33.59M | $31.87M | $35.34M | $36.44M | $38.16M | $23.51M |
| Net income | $124.11M | $133.75M | $118.07M | $81.28M | $100.27M | $111.24M | $125.95M | $110.74M |
| EBITDA | $174.10M | $195.46M | $174.89M | $142.08M | $163.78M | $171.64M | $188.65M | $164.82M |
| EPS (basic) | 13.50 | 14.54 | 12.62 | — | 10.67 | 11.84 | 13.26 | — |
| EPS (diluted) | 13.50 | 14.54 | 12.62 | — | 10.67 | 11.84 | 13.26 | — |
| Dividends declared per share | 3.00 | 3.00 | 3.00 | 3.00 | 2.75 | 2.75 | 2.75 | 2.50 |
| Weighted avg. shares (diluted) | 9.16M | 9.16M | 9.32M | — | 9.36M | 9.36M | 9.46M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $77.32M | $93.60M | $73.16M | $77.60M | $102.45M | $70.26M | $118.25M | $77.48M |
| Receivables | $449.89M | $480.73M | $438.44M | $422.08M | $438.79M | $453.71M | $463.34M | $395.45M |
| Inventory | $576.62M | $523.55M | $494.96M | $502.26M | $512.17M | $494.85M | $489.76M | $505.43M |
| Current assets | $1.16B | $1.15B | $1.06B | $1.06B | $1.10B | $1.07B | $1.12B | $1.03B |
| PP&E, net | $813.30M | $792.48M | $780.62M | $775.48M | $739.74M | $739.18M | $734.58M | $735.36M |
| Total assets | $3.65B | $3.62B | $3.50B | $3.49B | $3.23B | $3.19B | $3.23B | $3.13B |
| Current liabilities | $470.89M | $510.75M | $417.25M | $419.28M | $410.49M | $402.07M | $396.26M | $374.48M |
| Long-term debt | $830.05M | $854.83M | $939.61M | $883.39M | $783.10M | $841.83M | $990.55M | $971.28M |
| Total debt | $830.05M | $854.83M | $939.61M | $883.39M | $783.10M | $841.83M | $990.55M | $971.28M |
| Total liabilities | $1.72B | $1.78B | $1.77B | $1.71B | $1.54B | $1.58B | $1.71B | $1.67B |
| Shareholders' equity | $1.93B | $1.84B | $1.73B | $1.78B | $1.69B | $1.61B | $1.52B | $1.46B |
| Net debt | $752.74M | $761.23M | $866.45M | $805.79M | $680.65M | $771.57M | $872.30M | $893.80M |
| Shares outstanding | 9.20M | 9.20M | 9.20M | 9.40M | 9.40M | 9.40M | 9.43M | 9.52M |
| Cash flow statement | ||||||||
| Operating cash flow | $68.56M | $162.12M | $124.03M | $145.17M | $142.41M | $161.08M | $120.31M | $185.24M |
| Capital expenditure | $36.74M | $27.38M | $24.36M | $28.00M | $30.15M | $21.56M | $13.02M | $14.62M |
| Free cash flow | $31.81M | $134.75M | $99.68M | $117.17M | $112.26M | $139.52M | $107.30M | $170.62M |
| Investing cash flow | -$36.72M | -$27.38M | -$23.23M | -$241.44M | -$20.34M | -$16.28M | -$13.02M | -$14.62M |
| Financing cash flow | -$53.44M | -$114.22M | -$100.85M | $70.97M | -$85.90M | -$195.74M | -$68.47M | -$171.23M |
| Depreciation & amortization | $31.16M | $31.80M | $31.66M | $32.05M | $33.10M | $28.49M | $28.78M | $32.06M |
| Dividends paid | $27.59M | $27.59M | $27.96M | $28.19M | $25.84M | $25.84M | $26.06M | $23.94M |
| Share buybacks | $0 | $861,000 | $125.57M | $0 | $0 | $20.15M | $57.06M | $31.91M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.